BREAKING
Nexxen Q4 FY26 Earnings Results 14 hours ago Daktronics Q3 FY26 Earnings Results 14 hours ago Earnings Summary: SmartRent Returns to Growth in Q4FY25, Achieves Positive EBITDA. 16 hours ago Abercrombie & Fitch Q4 2025 Earnings Results 17 hours ago AutoZone (AZO) Q2 2026 earnings decline despite 8% sales growth 1 day ago Best Buy 4Q 2026: Earnings Analysis 2 days ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 3 days ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 3 days ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 3 days ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 6 days ago Nexxen Q4 FY26 Earnings Results 14 hours ago Daktronics Q3 FY26 Earnings Results 14 hours ago Earnings Summary: SmartRent Returns to Growth in Q4FY25, Achieves Positive EBITDA. 16 hours ago Abercrombie & Fitch Q4 2025 Earnings Results 17 hours ago AutoZone (AZO) Q2 2026 earnings decline despite 8% sales growth 1 day ago Best Buy 4Q 2026: Earnings Analysis 2 days ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 3 days ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 3 days ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 3 days ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 6 days ago
ADVERTISEMENT
Interviews

CERo Therapeutics CEO On Cancer Treatments

Chris Ehrlich, CEO of CERo Therapeutics, discusses the company’s novel approach to cancer immunotherapy and its CER-T platform. On Technology...

Interviews

Unicycive CEO On Kidney Care Focus

Dr. Shalabh Gupta, CEO of Unicycive Therapeutics, discusses the company’s focus on kidney care and its lead drug candidate for...